Guest View
User: Pass: | become a member
Author Archive for Insider Scoop

GM Said It Has Shipped Thousands of Replacement Ignition Switches

Courtesy of Benzinga.

General Motors on Wednesday said it has shipped “thousands” of kits needed to repair the defective ignition switches linked to at least 13 deaths.

Partner content
partner content url: 
http://www.foxbusiness.com/industries/2014/04/23/gm-said-it-has-shipped-thousands-replacement-ignition-switches/?cmpid=prn_benz

The following article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.





UPDATE: EMC Posts Drop In Q1 Earnings, Cuts 2014 Outlook

Courtesy of Benzinga.

Related EMC
Morning Market Losers
Earnings Scheduled For April 23, 2014

EMC (NYSE: EMC) reported a 32% drop in its first-quarter earnings and cut its earnings outlook for 2014.

EMC now expects 2014 earnings of $1.90 per share on revenue of $24.58 billion.

EMC’s quarterly profit fell to $392 million, or $0.19 per share, versus a year-ago profit of $580 million, or $0.26 per share. Excluding certain items, it earned $0.35 per share. The company had projected earnings of $0.35 per share.

Its revenue rose 1.7% to $5.48 billion, versus analysts’ estimates of $5.48 billion.

EMC’s board increased its quarterly dividend by 15% to 11.5 cents per share.

EMC shares fell 3.21% to $25.90 in pre-market trading.

Posted-In: profitEarnings News Guidance





Mid-Morning Market Update: Markets Fall; Boeing Profit Tops Street View

Courtesy of Benzinga.

Related BZSUM
#PreMarket Primer: Wednesday, April 23: Data From China Takes Some Pressure Off Beijing
Market Wrap For April 22: S&P Rises For Sixth Straight Day, Dow & Nasdaq Also Positive

Following the market opening Wednesday, the Dow traded down 0.13 percent to 16,492.37 while the NASDAQ tumbled 0.61 percent to 4,136.26. The S&P also fell, dropping 0.18 percent to 1,876.15.

Leading and Lagging Sectors
In trading on Wednesday, utilities shares were relative leaders, up on the day by about 0.61 percent. Top gainers in the sector included PPL (NYSE: PPL), Empresa Distribuidora y Comercializadora Norte SA (NYSE: EDN), and Public Service Enterprise Group (NYSE: PEG). Telecommunications services sector was the top decliner in the US market on Wednesday.

Top losers in the sector included China Unicom (Hong Kong) (NYSE: CHU), off 4.5 percent, and Black Box (NASDAQ: BBOX), down 3 percent.

Top Headline
The Boeing Company (NYSE: BA) reported better-than-expected first-quarter profit. Boeing’s quarterly profit declined to $965 million, or $1.28 per share, from a year-ago profit of $1.11 billion, or $1.44 per share. Its adjusted earnings surged to $1.76 per share compared to $1.73 per share. Its revenue climbed to $20.47 billion versus $18.89 billion. However, analysts were projecting earnings of $1.57 per share on revenue of $20.24 billion. For the full year, Boeing expects adjusted earnings of $7.15 to $7.35 per share.

Equities Trading UP
Xoom (NASDAQ: XOOM) shares shot up 15.58 percent to $22.77 after the company reported upbeat Q1 results and issued a strong FY14 outlook.

Shares of Elizabeth Arden (NASDAQ: RDEN) got a boost, shooting up 9.95 percent to $31.27. LG Household & Healthcare is considering a bid for Elizabeth Arden, according to Reuters.

Super Micro Computer (NASDAQ: SMCI) shares were also up, gaining 11.50 percent to $21.13 after the company reported…
continue reading





Have iPad Sales Peaked?

Courtesy of Benzinga.

Apple (NASDAQ: AAPL) has collectively sold more tablets than any other individual manufacturer, but its success may not continue in the coming months.

According to Gartner, Apple sold 70 million iPads in 2013. More than 100 million tablets were sold before that, which means that Apple should cross the 200 million mark this year.

Quarter after quarter, the iPad has proved to be a great source of profit for Apple, but its success story may not last forever. While Apple has endured hard times before, the company has managed to come out on top with iPad upgrades consumers can’t live without.

This could be why Apple is expected to release a 12-inch iPad — to reinvigorate sales of a product line that could be on the verge of deceleration.

Related:Panasonic’s New 4K Tablet Is 12X More Expensive Than Apple’s iPad Air

“I expect the iPhone to have a very good quarter, certainly,” Andy Hargreaves, Senior Research Analyst of Digital Media at Pacific Crest Securities, told Benzinga. “I expect to see further evidence of deceleration or saturation in the tablet market. I think they’ll have a good quarter for those product releases, but evidence of falling sales growth.”

Hargreaves does not expect any material sales changes for the Mac.

“I think you’ll see units sort of flat-ish on a year-over-year basis,” he said.

Apple TV: Still The Dominant Player

Fire TV may be the new kid on the block, but Apple’s set-top box is expected to continue dominating the market.

“I don’t know how much they’ll talk about it,” Hargreaves said of the set-top box. “It’s pretty small for them. I wouldn’t expect it to be down on a year-over-year basis. I think volumes will still be up a little bit. Even with the entrance of new competition, [Apple] and Roku kind of still dominate the markets. So I don’t expect a material change there.”

iPhone 6′s Big Evolution

There are new rumors that the 5.5-inch iPhone 6 will not be released this year, but Hargreaves doesn’t see this as a delay.

“We…
continue reading





Stocks To Watch For April 23, 2014

Courtesy of Benzinga.

Related PG
Will P&G (PG) Disappoint This Earnings Season? – Analyst Blog
Benzinga Weekly Preview: Earnings Season Kicks Into High Gear
Stocks Sell Off as Shift from Risk Persists (Fox Business)

Related FB
LinkedIn Hits 300M Global Members – Analyst Blog
Dragonfly Capital's Greg Harmon On Watching ETFs
WhatsApp Reaches 500M Users (Fox Business)

Some of the stocks that may grab investor focus today are:

Wall Street expects Procter & Gamble Company (NYSE: PG) to report its Q3 earnings at $1.02 per share on revenue of $20.68 billion. Procter & Gamble shares gained 0.15% to $81.37 in after-hours trading.

Analysts are expecting Facebook (NASDAQ: FB) to have earned $0.24 per share on revenue of $2.36 billion in the first quarter. Facebook shares rose 0.48% to $63.33 in after-hours trading.

Yum! Brands (NYSE: YUM) reported better-than-expected first-quarter earnings. Yum posted its adjusted net income of $0.87 per share, versus analysts’ estimates of $0.84 per share. Yum! Brands shares surged 3.58% to $80.25 in the after-hours trading session.

Delta Air Lines (NYSE: DAL) is expected to report its Q1 earnings at $0.29 per share on revenue of $8.92 billion. Delta shares climbed 1.72% to $35.55 in after-hours trading.

AT&T (NYSE: T) reported upbeat earnings for the first quarter and lifted its revenue forecast for the year. AT&T posted its adjusted profit of $0.71 per share on revenue of $32.5 billion. However, analysts were expecting earnings of $0.70 per share on revenue of $32.4 billion. AT&T shares fell 2.01% to $35.56 in the after-hours trading session.

Analysts expect Apple (NASDAQ: AAPL) to post its Q2 earnings at $10.18 per share on revenue of $43.53 billion. Apple shares slipped 0.03% to $531.55 in after-hours trading.

The Boeing Company (NYSE: BA) is projected to report its Q1 earnings at $1.56 per share on revenue of $20.19 billion. Boeing shares gained 1.58% to $129.57 in the after-hours trading session.

Posted-In: Stocks To WatchEarnings News Guidance Pre-Market Outlook Markets Trading Ideas





UPDATE: Boeing Posts Better-Than-Expected Q1 Earnings

Courtesy of Benzinga.

Related BA
#PreMarket Primer: Wednesday, April 23: Data From China Takes Some Pressure Off Beijing
Earnings Scheduled For April 23, 2014
Goldman: Buy United Tech Over Boeing (Fox Business)

Boeing Co (NYSE: BA) reported better-than-expected first-quarter profit.

Boeing’s quarterly profit declined to $965 million, or $1.28 per share, from a year-ago profit of $1.11 billion, or $1.44 per share. Its adjusted earnings surged to $1.76 per share compared to $1.73 per share.

Its revenue climbed to $20.47 billion versus $18.89 billion. However, analysts were projecting earnings of $1.57 per share on revenue of $20.24 billion.

For the full year, Boeing expects adjusted earnings of $7.15 to $7.35 per share.

Boeing shares rose 1.92% to $130.00 in pre-market trading.

Posted-In: profitEarnings News Guidance





Delhaize Group Announces Sale of Bosnian & Herzegovinian Stores

Courtesy of Benzinga.

Related DEG
Why Companhia Brasileira de Distribuicao (CBD) Has A Bright Short-Term Future? – Tale of the Tape
The Fresh Market (TFM) in Focus: Stock Moves 6.7% Higher – Tale of the Tape

Delhaize Group (Euronext Brussels: DELB, NYSE: DEG), the Belgian international food retailer, announces that it has signed an agreement with Tropic Group B.V. on the sale of its Bosnian & Herzegovinian stores.

Delhaize Group has signed an agreement with Tropic Group B.V., to divest all of its 39 Bosnian & Herzegovinian stores. Tropic Group B.V. is an entrepreneurial organization founded by Mr. Bojan Risovic. He is an established retailer with a long history of successfully running retail enterprises.

The transaction is expected to complete in the third quarter subject to regulatory approval and working capital adjustments.

» Delhaize Group

Delhaize Group is a Belgian international food retailer present in nine countries on three continents. At the end of 2013, Delhaize Group’s sales network consisted of 3 534 stores. In 2013, Delhaize Group posted €21.1 billion in revenues and €179 million in net profit (Group share). At the end of 2013, Delhaize Group employed approximately 160 000 people. Delhaize Group’s stock is listed on NYSE Euronext Brussels (DELB) and the New York Stock Exchange (DEG).

This press release is available in English, French and Dutch. You can also find it on the website www.delhaizegroup.com. Questions can be sent to investor@delhaizegroup.com.

» Contacts

Investor Relations: + 32 2 412 2151 Media Relations: + 32 2 412 8669

cautionary note regarding forward looking statements

Statements that are included or incorporated by reference in this press release and other written and oral statements made from time to time by Delhaize Group and its representatives, other than statements of historical fact, which address activities, events and developments that Delhaize Group expects or anticipates will or may occur in the future, including, without limitation, when the sale of Delhaize BH (Delhaize Group’s operations in Bosnia & Herzegovina) to Tropic Group B.V. is expected to be completed; the financial flexibility that will result from the sale; the ultimate value of the transaction to Delhaize Group after working capital adjustments, expected costs savings, the…
continue reading





Actavis Completes Divestiture of Commercial Operations in Seven Western European Countries to Aurobindo Pharma Limited

Courtesy of Benzinga.

Actavis plc (NYSE: ACT) today announced that it has successfully completed the divestiture of its generics commercial operations in seven markets in Western Europe to Aurobindo Pharma Limited (BSE: 524804). The agreement to divest the commercial operations was announced in January 2014.

Actavis plc logo Aurobindo acquired Actavis’ pharmaceutical commercial infrastructure in France, Italy, Spain, Portugal, Belgium, Germany and the Netherlands, including products, marketing authorizations and dossier license rights. The two companies also entered into a long-term strategic supply arrangement.

About Actavis Actavis plc (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. Actavis has global headquarters in Dublin, Ireland and U.S. administrative headquarters in Parsippany, New Jersey, USA.

Actavis develops and manufactures generic, brand, branded generic, legacy brands and Over-the-Counter (OTC) pharmaceutical products and has commercial operations in approximately 60 countries. The Company’s North American branded pharmaceuticals business is focused principally in the Women’s Health, Urology, Gastroenterology and Dermatology therapeutic categories with a strong pipeline of products in various stages of development. Actavis also has a portfolio of five biosimilar products in development in Women’s Health and Oncology. Actavis Global Operations has more than 30 manufacturing and distribution facilities around the world, and includes Anda, Inc., a U.S. pharmaceutical product distributor.

For press release and other company information, visit Actavis’ Web site at http://www.actavis.com.

About Aurobindo Aurobindo Pharma Limited (www.aurobindo.com), headquartered at Hyderabad, India, manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s manufacturing facilities are approved by several leading regulatory agencies like US FDA, UK MHRA, WHO, Health Canada, MCC South Africa, ANVISA Brazil. The company’s robust product portfolio is spread over 6 major therapeutic/product areas encompassing Antibiotics, Anti-Retrovirals, CVS, CNS, Gastroenterologicals, and Anti-Allergics, supported by an outstanding R&D set-up. The Company is marketing these products globally, in over 125 countries.

Aurobindo Europe represents a significant segment within the Group’s global presence. Aurobindo is committed to grow its operations in Europe considering the importance of the generic market. Since launching its European commercial operations in 2006 with the acquisition of Milpharm in the UK and Pharmacin in the Netherlands in 2007, Aurobindo has further expanded its footprint in continental Europe by commencing…
continue reading





Pernix Agrees to Divest Manufacturing Facility

Courtesy of Benzinga.

Related PTX
Mid-Afternoon Market Update: Markets Continue to Take a Beating as Rite Aid Moves Higher
Mid-Day Market Update: Rite Aid Shares Gain On Upbeat Earnings; Imperva Drops

Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NASDAQ MKT:PTX), a specialty pharmaceutical company, today announced that it has signed a definitive agreement to divest its Houston, TX-based manufacturing operations, Pernix Manufacturing, LLC (“PML”) to Woodfield Pharmaceutical LLC (“Woodfield”).

Woodfield will acquire the entire PML operation and will assume the mortgage associated with the facility. Pernix expects to receive approximately $1.2 million in net proceeds at closing and realize approximately $5.0 million in annualized cost savings from the divestiture. As part of the agreement, Woodfield will continue to manufacture the existing Pernix products under a long-term supply agreement. Pernix anticipates a closing of April 15, 2014. Closing of the transaction is subject to standard closing conditions and deliveries. In addition, closing on the sale of certain of the real estate assets may extend beyond the anticipated closing date.

Commenting on the sale, Doug Drysdale, President and CEO of Pernix said, “The sale of PML, along with the previously-announced closure of our distribution centers in Madison, MS and Magnolia, TX continues our efforts to reduce and simplify our operating costs. The transaction will be a significant contributor to profitability in 2014. We sincerely appreciate the contributions the PML team has made as part of the Pernix family and we look forward to working together with Woodfield to effect a smooth transition.”

Adam Runsdorf, President of Woodfield Pharmaceutical, LLC said, “We are pleased to participate in this transaction with Pernix and look forward to expanding the current platform of operations which will be dedicated to the service of existing and future customers requiring outsourced contract manufacturing.”

About Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics is a specialty pharmaceutical company primarily focused on the sales, marketing, manufacturing and development of branded pharmaceutical products. The Company markets a portfolio of branded products, including: CEDAX®, an antibiotic for middle ear infections and a number of treatments for cough and cold conditions including ZUTRIPRO®, REZIRA® and VITUZ®. The Company also markets SILENOR, a…
continue reading





FelCor Agrees to Sell Doubletree Suites in Charlotte for $37M

Courtesy of Benzinga.

FelCor Lodging Trust Incorporated (NYSE: FCH) today announced that it has agreed to sell the 208-room Doubletree Suites Hotel Charlotte-SouthPark for $37 million. The purchaser has paid a $900,000 non-refundable deposit toward the purchase price. FelCor expects the sale to close in May.

FelCor continues to progress with its portfolio repositioning plan. The Company is currently negotiating contracts or has agreed to sell four other hotels for aggregate proceeds of approximately $80 million. FelCor will use the proceeds from selling these assets to repay outstanding debt. To date, FelCor has sold 26 non-strategic hotels as part of its plan.

About FelCor

FelCor, a real estate investment trust, owns a diversified portfolio of primarily upper-upscale and luxury hotels that are located in major and resort markets throughout the U.S. FelCor partners with leading hotel companies to operate its hotels, which are flagged under globally renowned names and premier independent hotels. Additional information can be found on the Company’s website at www.felcor.com.

With the exception of historical information, the matters discussed in this news release include “forward-looking statements” within the meaning of the federal securities laws that are qualified by cautionary statements herein and in FelCor’s filings with the Securities and Exchange Commission. We undertake no obligation to update any forward-looking statement to conform the statement to actual results or changes in our expectations.

Posted-In: News Asset Sales





 
 
 

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Zero Hedge

Housing Bubble Pop 2.0: Remodeling Collapses To 1 Year Low

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

On the way up, every sell-side strategist points to remodeling as a leading indicator for the housing recovery as confidence in the value of their home prompts real people to "invest" in upgrades and remodel their homes. That has been the story... until now. As NARI reports, the Remodeling Business Pulse (RBP) data of current and future remodeling business conditions show current condition ratings fell significantly in March - in fact they fell from multi-year highs to one-year lows as "homeowners remain slow to make the decision to move ahead with higher-priced projects."...



more from Tyler

Phil's Favorites

Cost Of "Breakfast In America" Soars To Highest In Over 2 Years

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

Another day, another indication that 'real' inflation - the kind that reduces standards of living and leeches away purchasing power for 'real' people - is anything but under control... and anything but stable.

With the Oz-ians in the Eccles Building pulling levers to run the world based on their "inflation" measures, it seems that if the price of 'things that matter' soars but the Fed doesn't see them, there is no need to tighten. Last week we discussed the surge in the price of beef, ...



more from Ilene

Chart School

Dead-Cat Bounce Over for the Housing Market?

Courtesy of Doug Short.

Advisor Perspectives welcomes guest contributions. The views presented here do not necessarily represent those of Advisor Perspectives.

I have been saying this for a while: You can't have a housing recovery unless actual home buyers are involved.

We are very far away from seeing the housing market reach its 2005 highs ... and as time passes, it becomes clearer that this generation may never see them again.

How can I say that?

What we have seen in the housing market since then, but mostly since 2012, in my opinion, is nothing more than a dead-cat bounce scenario -- an increase in prices after a massive decline. The chart below shows how far off we are from the housing prices of 2005.


Chart courtesy of www.StockCharts.com

One of the key indicators I follow in ...



more from Chart School

Insider Scoop

GM Said It Has Shipped Thousands of Replacement Ignition Switches

Courtesy of Benzinga.

General Motors on Wednesday said it has shipped "thousands" of kits needed to repair the defective ignition switches linked to at least 13 deaths.

Partner content partner content url:  http://www.foxbusiness.com/industries/2014/04/23/gm-said-it-has-shipped-thousands-replacement-ignition-switches/?cmpid=prn_benz

The following article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.

...

http://www.insidercow.com/ more from Insider

Market Shadows

Soy Numero Uno

Soy Numero Uno

By Paul Price of Market Shadows

Bunge Limited (BG) is the world’s largest processor of soybeans. It is also a major producer of vegetable oils, fertilizer, sugar and bioenergy.

When commodities got hot in 2007-08, Bunge’s EPS shot up and the stock followed, rising 185% in 19 months.

The Great Recession took its toll on operations, dropping EPS to a low of $2.22 in 2009.  Since then profits have recovered.  They ranged from $4.62 - $5.90 in the latest three years. 2014 appears poised for a large increase. Consensus views from multiple sources see BG earning $7.04 - $7.10 this year and then $7.83 - $7.94 in 2015.

...



more from Paul

Option Review

Casino Stocks LVS, WYNN On The Run Ahead of Earnings

Shares in Las Vegas Sands Corp. (Ticker: LVS) are up sharply today, gaining as much as 5.7% to touch $80.12 and the highest level since April 4th, mirroring gains in shares of resort casino operator Wynn Resorts Ltd. (Ticker: WYNN). The move in Wynn shares appears, at least in part, to follow a big increase in target price from analysts at CLSA who upped their target on the ‘buy’ rated stock to $350 from $250 a share. CLSA also has a ‘buy’ rating on Las Vegas Sands with a $100 price target according to a note from reporter, Janet Freund, on Bloomberg. Both companies are scheduled to report first-quarter earnings after the closing bell on Thursday.

...

more from Caitlin

Sabrient

What the Market Wants: Market Poised to Head Higher: 3 Stocks to Consider

Reminder: Sabrient is available to chat with Members, comments are found below each post.

Courtesy of David Brown, Sabrient Systems and Gradient Analytics

Yesterday, the market continued its winning ways for the fifth consecutive day.  The S&P 500 closed within 1% of its all-time high, and the DJI was even closer to its all-time high.  Healthcare, Energy and Technology led the sectors while Financials, Telecom, and Utilities finished slightly in the red.  All three sectors in the red are typically flight-to-safety stocks, so despite lower than average volume, the market appears poised to make new highs.

Mid-cap Growth led the style/caps last week, up 2.87%, and Small-cap Growth trailed, up 2.22%. This week will bring well over 100 S&P 500 stocks reporting their March quarter earn...



more from Sabrient

OpTrader

Swing trading portfolio - Week of April 21st, 2014

Reminder: OpTrader is available to chat with Members, comments are found below each post.

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here...



more from OpTrader

Stock World Weekly

Stock World Weekly

Newsletter writers are available to chat with Members regarding topics presented in SWW, comments are found below each post.

Here's this week's Stock World Weekly. Click here and sign in with your PSW user name and password, or sign up for a free trial.

...

more from SWW

Digital Currencies

Facebook Takes Life Seriously and Moves To Create Its Own Virtual Currency, Increases UltraCoin Valuation Significantly

Courtesy of ZeroHedge. View original post here.

Submitted by Reggie Middleton.

The Financial Times reports:

[Facebook] The social network is only weeks away from obtaining regulatory approval in Ireland for a service that would allow its users to store money on Facebook and use it to pay and exchange money with others, according to several people involved in the process. 

The authorisation from Ireland’s central bank to become an “e-money” institution would allow ...



more from Bitcoin

Promotions

See Live Demo Of This Google-Like Trade Algorithm

I just wanted to be sure you saw this.  There’s a ‘live’ training webinar this Thursday, March 27th at Noon or 9:00 pm ET.

If GOOGLE, the NSA, and Steve Jobs all got together in a room with the task of building a tremendously accurate trading algorithm… it wouldn’t just be any ordinary system… it’d be the greatest trading algorithm in the world.

Well, I hate to break it to you though… they never got around to building it, but my friends at Market Tamer did.

Follow this link to register for their training webinar where they’ll demonstrate the tested and proven Algorithm powered by the same technological principles that have made GOOGLE the #1 search engine on the planet!

And get this…had you done nothing b...



more from Promotions

Pharmboy

Here We Go Again - Pharma & Biotechs 2014

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Ladies and Gentlemen, hobos and tramps,
Cross-eyed mosquitoes, and Bow-legged ants,
I come before you, To stand behind you,
To tell you something, I know nothing about.

And so the circus begins in Union Square, San Francisco for this weeks JP Morgan Healthcare Conference.  Will the momentum from 2013, which carried the S&P Spider Biotech ETF to all time highs, carry on in 2014?  The Biotech ETF beat the S&P by better than 3 points.

As I noted in my previous post, Biotechs Galore - IPOs and More, biotechs were rushing to IPOs so that venture capitalists could unwind their holdings (funds are usually 5-7 years), as well as take advantage of the opportune moment...



more from Pharmboy



FeedTheBull - Top Stock market and Finance Sites



About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>